Author/Authors :
Eishei Oskuei, Ali Uromia University of Medical Sciences, ايران , Makhdoomi, Khadijeh Nephrology and Kidney Transplant Research Center, ايران , Abkhiz, Saeed Uromia University of Medical Sciences, ايران , Vossoghian, Sara Uromia University of Medical Sciences, ايران , Farrokhpour, Mohsen Uromia University of Medical Sciences, ايران
Abstract :
Chronic Myelogenic Leukemia (CML) is a rare malignant disorder after solid organ transplantation, especially in renal transplant recipi- ents. lmatinib Mesylate is currently approved as first line treatment of CML. Most reports on CML are from kidney recipients who received azathioprine in combination with cyclosporine and prednisolone as immunosuppressive therapy. We report a case with CML who was treated with Mycophenolate Mofetil.
